5 completed. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Chronic Iron Overload: new trials by email Literature Review of Chronic Iron Overload trials Research Report on Chronic Iron Overload
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Survey to Assess Physicians' Knowledge of Exjade Posology and Biological Monitoring Recommendations as Described in the Educational Materials Physician survey - Chronic Iron Overload | Completed | Novartis Pharmaceuticals | 400 | 2024-01-12 | 2024-05-17 | |
| Extended Evaluation of Deferasirox Film-coated Tablet (FCT) Formulation Deferasirox - Chronic Iron Overload | Phase 3 | Completed | Novartis Pharmaceuticals | 53 | 2016-08-16 | 2020-03-03 |
| Study to Assess Iron Chelation Therapy in Patients With Chronic Iron Overload Iron chelator - Chronic Iron Overload | Completed | Novartis Pharmaceuticals | 489 | 2015-09-15 | 2022-10-21 | |
| Efficacy/Safety Study of Deferiprone Compared to Deferasirox in Paediatric Patients Deferiprone, Deferasirox - Chronic Iron Overload | Phase 3 | Completed | Consorzio per Valutazioni Biologiche e Farmacologiche | 435 | 2014-03-17 | 2021-05-04 |
| Pharmacokinetic Study of Deferiprone in Paediatric Patients Deferiprone, dose level 1, Deferiprone, dose level 2, Deferiprone, dose level 3 - Chronic Iron Overload | Phase 2 | Completed | Consorzio per Valutazioni Biologiche e Farmacologiche | 23 | 2012-12-01 | 2017-01-11 |
beta-Thalassemia (2) · Anemia (1) · Iron Overload (1) · Myelodysplastic Syndromes (1) · Thalassemia (1)
Anemia, Hemolytic (3) · Anemia, Hemolytic, Congenital (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Genetic Diseases, Inborn (3) · Hematologic Diseases (3) · Hemic and Lymphatic Diseases (3) · Hemoglobinopathies (3) · Anemia (2) · Thalassemia (2) · Bone Marrow Diseases (1) · Iron Metabolism Disorders (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1)
Deferasirox (2) · Deferiprone (2) · Isoflurophate (2)
Novartis Pharmaceuticals (3) · Consorzio per Valutazioni Biologiche e Farmacologiche (2)
Italy (3) · Cyprus (2) · Egypt (2) · Greece (2) · Albania (1) · Austria (1) · Germany (1) · Switzerland (1) · Tunisia (1) · United Kingdom (1)
Aurelio Maggio, MD (1) · Donato Bonifazi, Dr (1) · Giovanni Carlo Del Vecchio (1) · Oscar Della Pasqua (1)